US Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals

Watchlist

2.600
-0.240-8.45%

Close Jul 17 16:00 ET

2.840
+0.240+9.23%

Post 19:39 ET

92.62MMarket Cap-2166P/E (TTM)

Eupraxia Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-34.01%-6.12M

-43.68%-20.68M

-34.91%-6.11M

-42.04%-5.62M

-56.77%-4.38M

-46.79%-4.57M

-25.36%-14.4M

-62.42%-4.53M

-126.05%-3.96M

19.65%-2.79M

Net income from continuing operations

-55.63%-6.16M

-52.53%-28.97M

-28.63%-10.86M

-199.64%-8.27M

-23.14%-5.89M

-31.37%-3.96M

-3.61%-18.99M

-184.32%-8.44M

25.45%-2.76M

-3.04%-4.78M

Operating gains losses

844.56%144.91K

72.44%-59.76K

-269.68%-57.59K

99.47%-1.13K

120.56%18.42K

-136.25%-19.46K

-122.96%-216.83K

8.15%33.94K

-31.62%-214.87K

-232.17%-89.6K

Depreciation and amortization

-0.10%37.42K

5.16%155.53K

-0.03%46.86K

7.21%34.86K

-1.68%36.35K

18.79%37.46K

69.08%147.89K

44.22%46.88K

46.05%32.52K

121.74%36.97K

Other non cash items

1.68%160.94K

-11.20%586K

-65.06%107.28K

-46.06%-40.6K

102.72%361.03K

-21.87%158.29K

-75.32%659.95K

49.77%307.07K

-117.04%-27.79K

-59.51%178.09K

Change In working capital

117.63%250.12K

253.35%5.35M

232.25%5.51M

130.08%299.5K

-41.95%964.91K

-75.31%-1.42M

1,013.35%1.51M

419.20%1.66M

-159.86%-995.65K

861.03%1.66M

-Change in receivables

919.02%17.2K

-145.00%-103.71K

-161.48%-124.11K

-46.68%-18.49K

-21.11%37.21K

128.34%1.69K

53.95%230.48K

178.68%201.88K

79.53%-12.61K

-86.74%47.17K

-Change in prepaid assets

143.49%125.2K

-206.40%-122.44K

-123.48%-10.46K

-33.27%79.26K

-19.27%-242.65K

31,838.22%51.42K

-178.18%-39.96K

-74.85%44.54K

-33.68%118.78K

-197.90%-203.44K

-Change in payables and accrued expense

107.32%107.71K

321.28%5.58M

299.82%5.64M

121.67%238.73K

-35.65%1.17M

-83.18%-1.47M

461.12%1.32M

420.86%1.41M

-171.28%-1.1M

1,688.39%1.82M

Cash from discontinued investing activities

Operating cash flow

-34.01%-6.12M

-43.68%-20.68M

-34.91%-6.11M

-42.04%-5.62M

-56.77%-4.38M

-46.79%-4.57M

-25.36%-14.4M

-62.42%-4.53M

-126.05%-3.96M

19.65%-2.79M

Investing cash flow

Cash flow from continuing investing activities

15.85%-6.79K

-100.75%-73.38K

-100.30%-49.69K

-102.41%-9.01K

99.91%-6.61K

-48.63%-8.07K

186.78%9.83M

334.36%16.57M

314.95%373.94K

-9,572.21%-7.11M

Net PPE purchase and sale

15.85%-6.79K

68.82%-73.38K

31.33%-49.69K

69.34%-9.01K

94.84%-6.61K

-48.63%-8.07K

30.50%-235.31K

-405.82%-72.36K

90.81%-29.4K

-11,244.46%-128.12K

Net investment purchase and sale

----

--0

----

242.66%10.07M

335.80%16.64M

--403.34K

----

Cash from discontinued investing activities

Investing cash flow

15.85%-6.79K

-100.75%-73.38K

-100.30%-49.69K

-102.41%-9.01K

99.91%-6.61K

-48.63%-8.07K

186.78%9.83M

334.36%16.57M

314.95%373.94K

-9,572.21%-7.11M

Financing cash flow

Cash flow from continuing financing activities

11,797.52%23.15M

94.55%21.01M

-83.98%188.71K

2,667.82%16.09M

-55.88%4.54M

638.09%194.61K

-72.41%10.8M

1,271.48%1.18M

22.15%-626.69K

27.89%10.29M

Net issuance payments of debt

-3.36%-36.82K

-1.52%-144.44K

10.39%-37.52K

-12.83%-34.03K

-9.38%-37.27K

1.51%-35.62K

-101.50%-142.27K

46.42%-41.87K

-163.34%-30.16K

-100.45%-34.08K

Net common stock issuance

--22.85M

49.36%15.89M

-94.75%47.92K

2,755.10%15.84M

--0

-64.15%10.64M

4,173.22%912.94K

30.03%-596.54K

1,807.19%10.32M

Proceeds from stock option exercised by employees

46.46%337.2K

1,618.51%5.27M

-41.88%178.31K

--287.77K

--4.58M

--230.23K

--306.77K

--0

----

Cash from discontinued financing activities

Financing cash flow

11,797.52%23.15M

94.55%21.01M

-83.98%188.71K

2,667.82%16.09M

-55.88%4.54M

638.09%194.61K

-72.41%10.8M

1,271.48%1.18M

22.15%-626.69K

27.89%10.29M

Net cash flow

Beginning cash position

5.90%19.34M

45.75%18.26M

183.07%24.43M

6.75%14.41M

3.01%13.93M

9.14%18.26M

10,542.18%12.53M

-67.30%8.63M

-53.61%13.5M

-45.15%13.52M

Current changes in cash

488.67%17.03M

-95.88%256.97K

-145.20%-5.97M

348.43%10.46M

-60.80%151.32K

-38.94%-4.38M

-61.79%6.24M

232.69%13.22M

-54.25%-4.21M

-91.41%386.04K

Effect of exchange rate changes

-1,122.24%-460.76K

261.89%821.4K

197.55%819K

-89.67%29.04K

-164.62%-71.72K

175.10%45.07K

-692.55%-507.4K

-1,689.49%-839.6K

765.41%281.24K

323.75%110.98K

End cash Position

157.81%35.91M

5.90%19.34M

183.07%24.43M

6.75%14.41M

3.01%13.93M

11.46%18.26M

-67.30%8.63M

-53.61%13.5M

Free cash flow

-33.92%-6.13M

-41.87%-20.76M

-33.87%-6.16M

-41.22%-5.63M

-50.11%-4.39M

-46.80%-4.58M

-23.76%-14.63M

-64.18%-4.6M

-92.53%-3.99M

15.98%-2.92M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-34.01%-6.12M	-43.68%-20.68M	-34.91%-6.11M	-42.04%-5.62M	-56.77%-4.38M	-46.79%-4.57M	-25.36%-14.4M	-62.42%-4.53M	-126.05%-3.96M	19.65%-2.79M
Net income from continuing operations	-55.63%-6.16M	-52.53%-28.97M	-28.63%-10.86M	-199.64%-8.27M	-23.14%-5.89M	-31.37%-3.96M	-3.61%-18.99M	-184.32%-8.44M	25.45%-2.76M	-3.04%-4.78M
Operating gains losses	844.56%144.91K	72.44%-59.76K	-269.68%-57.59K	99.47%-1.13K	120.56%18.42K	-136.25%-19.46K	-122.96%-216.83K	8.15%33.94K	-31.62%-214.87K	-232.17%-89.6K
Depreciation and amortization	-0.10%37.42K	5.16%155.53K	-0.03%46.86K	7.21%34.86K	-1.68%36.35K	18.79%37.46K	69.08%147.89K	44.22%46.88K	46.05%32.52K	121.74%36.97K
Other non cash items	1.68%160.94K	-11.20%586K	-65.06%107.28K	-46.06%-40.6K	102.72%361.03K	-21.87%158.29K	-75.32%659.95K	49.77%307.07K	-117.04%-27.79K	-59.51%178.09K
Change In working capital	117.63%250.12K	253.35%5.35M	232.25%5.51M	130.08%299.5K	-41.95%964.91K	-75.31%-1.42M	1,013.35%1.51M	419.20%1.66M	-159.86%-995.65K	861.03%1.66M
-Change in receivables	919.02%17.2K	-145.00%-103.71K	-161.48%-124.11K	-46.68%-18.49K	-21.11%37.21K	128.34%1.69K	53.95%230.48K	178.68%201.88K	79.53%-12.61K	-86.74%47.17K
-Change in prepaid assets	143.49%125.2K	-206.40%-122.44K	-123.48%-10.46K	-33.27%79.26K	-19.27%-242.65K	31,838.22%51.42K	-178.18%-39.96K	-74.85%44.54K	-33.68%118.78K	-197.90%-203.44K
-Change in payables and accrued expense	107.32%107.71K	321.28%5.58M	299.82%5.64M	121.67%238.73K	-35.65%1.17M	-83.18%-1.47M	461.12%1.32M	420.86%1.41M	-171.28%-1.1M	1,688.39%1.82M
Cash from discontinued investing activities
Operating cash flow	-34.01%-6.12M	-43.68%-20.68M	-34.91%-6.11M	-42.04%-5.62M	-56.77%-4.38M	-46.79%-4.57M	-25.36%-14.4M	-62.42%-4.53M	-126.05%-3.96M	19.65%-2.79M
Investing cash flow
Cash flow from continuing investing activities	15.85%-6.79K	-100.75%-73.38K	-100.30%-49.69K	-102.41%-9.01K	99.91%-6.61K	-48.63%-8.07K	186.78%9.83M	334.36%16.57M	314.95%373.94K	-9,572.21%-7.11M
Net PPE purchase and sale	15.85%-6.79K	68.82%-73.38K	31.33%-49.69K	69.34%-9.01K	94.84%-6.61K	-48.63%-8.07K	30.50%-235.31K	-405.82%-72.36K	90.81%-29.4K	-11,244.46%-128.12K
Net investment purchase and sale	----	--0	--0	--0	----	----	242.66%10.07M	335.80%16.64M	--403.34K	----
Cash from discontinued investing activities
Investing cash flow	15.85%-6.79K	-100.75%-73.38K	-100.30%-49.69K	-102.41%-9.01K	99.91%-6.61K	-48.63%-8.07K	186.78%9.83M	334.36%16.57M	314.95%373.94K	-9,572.21%-7.11M
Financing cash flow
Cash flow from continuing financing activities	11,797.52%23.15M	94.55%21.01M	-83.98%188.71K	2,667.82%16.09M	-55.88%4.54M	638.09%194.61K	-72.41%10.8M	1,271.48%1.18M	22.15%-626.69K	27.89%10.29M
Net issuance payments of debt	-3.36%-36.82K	-1.52%-144.44K	10.39%-37.52K	-12.83%-34.03K	-9.38%-37.27K	1.51%-35.62K	-101.50%-142.27K	46.42%-41.87K	-163.34%-30.16K	-100.45%-34.08K
Net common stock issuance	--22.85M	49.36%15.89M	-94.75%47.92K	2,755.10%15.84M	--0	--0	-64.15%10.64M	4,173.22%912.94K	30.03%-596.54K	1,807.19%10.32M
Proceeds from stock option exercised by employees	46.46%337.2K	1,618.51%5.27M	-41.88%178.31K	--287.77K	--4.58M	--230.23K	--306.77K	--306.77K	--0	----
Cash from discontinued financing activities
Financing cash flow	11,797.52%23.15M	94.55%21.01M	-83.98%188.71K	2,667.82%16.09M	-55.88%4.54M	638.09%194.61K	-72.41%10.8M	1,271.48%1.18M	22.15%-626.69K	27.89%10.29M
Net cash flow
Beginning cash position	5.90%19.34M	45.75%18.26M	183.07%24.43M	6.75%14.41M	3.01%13.93M	9.14%18.26M	10,542.18%12.53M	-67.30%8.63M	-53.61%13.5M	-45.15%13.52M
Current changes in cash	488.67%17.03M	-95.88%256.97K	-145.20%-5.97M	348.43%10.46M	-60.80%151.32K	-38.94%-4.38M	-61.79%6.24M	232.69%13.22M	-54.25%-4.21M	-91.41%386.04K
Effect of exchange rate changes	-1,122.24%-460.76K	261.89%821.4K	197.55%819K	-89.67%29.04K	-164.62%-71.72K	175.10%45.07K	-692.55%-507.4K	-1,689.49%-839.6K	765.41%281.24K	323.75%110.98K
End cash Position	157.81%35.91M	5.90%19.34M	5.90%19.34M	183.07%24.43M	6.75%14.41M	3.01%13.93M	11.46%18.26M	11.46%18.26M	-67.30%8.63M	-53.61%13.5M
Free cash flow	-33.92%-6.13M	-41.87%-20.76M	-33.87%-6.16M	-41.22%-5.63M	-50.11%-4.39M	-46.80%-4.58M	-23.76%-14.63M	-64.18%-4.6M	-92.53%-3.99M	15.98%-2.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall